Most Read News

Sales rise 99.14% to Rs 4.64 crore

ONGC: The state-run oil majors consolidated net profit surged 334.12% to Rs 10,931.61 crore on 45.27% rise in net sales to Rs 145,685.58 crore in Q3 December 2021 over Q3 December 2020. Dr. Reddys Laboratories: The pharma major announced that it has entered into an exclusive sales and distribution agreement with Novartis India (NIL) for the Voveran range, the Calcium range and Methergine in India. […]

Dr ReddyS Laboratories has entered into an exclusive sales and distribution agreement with Novartis India (NIL) for the Voveran range, the calcium range and Methergine in India.

Net income increases 45% yoy to Rs1,716 million in Q3FY22. Net interest margin for Q3FY22 was 10.3%.

Consolidated results could be aided VECV segment which will be incorporated in the financials as 'share of profits from JV' under Ind-AS.

New products developed for electric mobility have received a good response in the market.

Sales decline 17.84% to Rs 895.02 crore

Sales rise 30.00% to Rs 256.17 crore

Sales rise 40.65% to Rs 6280.46 crore

The Indian rupee is expected to be under pressure in opening trades on Monday, 14 February 2022 amid mounting tension between Russia and Ukraine. Besides, surging crude oil prices and dollar surge in unlikely to provide support to the local currency. Moreover, domestic industrial output slumped to a 10-month low of 0.4% in December, dragged down by manufacturing, capital goods and consumer durables output along […]